HALIFAX -- New Brunswick health officials are reporting a person in the province has died due to blood clotting from the AstraZeneca COVID-19 vaccine, but still recommending its use. This is the second case of blood clotting from the AstraZeneca vaccine in the province, but the first death from the resulting Thrombosis-thrombocytopenia syndrome (TTS). New Brunswick Chief Medical Officer of Health Dr. Jennifer Russell started Wednesday's media conference by extending her condolences to the family of the deceased, who she said was in their 60s. "Your loss is deeply felt by all of your fellow New Brunswickers," said Russell. Russell said the person was given a dose of the AstraZeneca COVID-19 vaccine in mid-April, and developed symptoms of TTS seven days after immunization.